CinCor Pharma Inc.

NASDAQ: CINC · Real-Time Price · USD
29.06
0.00 (0.00%)
At close: Feb 23, 2023, 10:00 PM

CinCor Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-20.98M -21.08M -16.7M -29.34M -9.02M -6.38M -5.62M
Depreciation & Amortization
4.21K n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
1.3M 1.24M 1.22M 748.63K 448.24K 412.95K 1.39M
Other Working Capital
4.57M 2.69M -8.93M 7.74M -2.04M -1.62M -1.84M
Other Non-Cash Items
-253.84K -140.22K 3.01M 13.64M 1.34M 1.21M 1.21M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
4.81M 420.95K -5.25M 3.93M 1M -3.05M -2.76M
Operating Cash Flow
-15.11M -19.55M -17.71M -11.03M -6.24M -7.81M -5.77M
Capital Expenditures
-63.2K n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-108.17M -67.39M -159.84M n/a n/a n/a n/a
Sales Maturities Of Investments
45M 50M 10M n/a n/a n/a n/a
Other Investing Acitivies
n/a -42.14K n/a n/a n/a n/a n/a
Investing Cash Flow
-63.23M -17.43M -149.84M n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
243.28M -3 195.55M 5.92M 134.22M 1.23M n/a
Financial Cash Flow
243.28M -3 195.55M 5.92M 134.22M 1.23M n/a
Net Cash Flow
164.94M -36.98M 28M -5.1M 127.98M -6.58M -5.77M
Free Cash Flow
-15.18M -19.55M -17.71M -11.03M -6.24M -7.81M -5.77M